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Abstract
Genome-wide association studies (GWASs) have identified a number of
susceptibility genes for schizophrenia (SCZ) and bipolar disorder (BD). However,
the identification of risk genes for major depressive disorder (MDD) has been
unsuccessful because the etiology of MDD is more influenced by environmental
factors; thus, gene–environment (G6E) interactions are important, such as
interplay with stressful life events (SLEs). We assessed the G6E interactions and
main effects of genes targeting depressive symptoms. Using a case–control
design, 922 hospital staff members were evaluated for depressive symptoms
according to Beck Depressive Inventory (BDI; ‘‘depression’’ and ‘‘control’’ groups
were classified by scores of 10 in the BDI test), SLEs, and personality. A total of
sixty-three genetic variants were selected on the basis of previous GWASs of MDD,
SCZ, and BD as well as candidate-gene (SLC6A4, BDNF, DBH, and FKBP5)
studies. Logistic regression analysis revealed a marginally significant interaction
(genetic variant 6 SLE) at rs4523957 (Puncorrected50.0034) with depression and a
significant association of single nucleotide polymorphism identified from evidence
of BD GWAS (rs7296288, downstream of DHH at 12q13.1) with depression as the
main effect (Puncorrected59.4610
24, Pcorrected50.0424). We also found that SLEs
had a larger impact on depression (odds ratio,3), as reported previously. These
results suggest that DHH plays a possible role in depression etiology; however,
variants from MDD or SCZ GWAS evidence or candidate genes showed no
significant associations or minimal effects of interactions with SLEs on depression.
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Introduction
Major depressive disorder (MDD) is a common and debilitating disorder with
pervasive impact on the quality of life of patients and their families.
Approximately 15% of the general population suffers from this condition
throughout their life spans [1]. Several lines of evidence from epidemiological
studies suggest that the heritability of MDD is significant but modest
(approximately 40%) [2]; thus, numerous genetic association studies on
candidate genes and, more recently, genome-wide association studies (GWASs)
have been conducted. However, no risk gene for MDD [3] has been identified till
date, although GWASs for other psychiatric disorders such as schizophrenia
(SCZ) [4] and bipolar disorder (BD) [5] have identified a number of risk genes.
One possible reason for the failure to identify MDD-related genes has been
suggested from the phenotyping of MDD. Despite the development of
standardized diagnostic manuals for general psychiatry, such as the Diagnostic
and Statistical Manual of Mental Disorders (DSM) and International Statistical
Classification of Diseases and Related Health Problems (ICD), the diagnostic
reliability for MDD is insufficient [6]. In addition, together with the high
prevalence of MDD, the definition of ‘‘healthy controls’’ as comparative subjects
is difficult in case–control studies; even if the ‘‘controls’’ have not been diagnosed
for MDD at the time of enrollment, the high prevalence of MDD does not ensure
the future development of MDD. Therefore, a very large number of samples is
required to compensate for the loss of statistical power. However, even in mega-
analysis of GWASs, in which the largest samples were analyzed, no risk of single
nucleotide polymorphism (SNP) with genome-wide significance has been
identified [3].
Another concern that should be considered involves the environmental or
clinical factors. Among these, the promising candidates are sex (male/female),
stressful life events (SLEs), personality traits (specifically neuroticism), and age. In
particular, SLEs have the potential for interactions with genetic components; most
studies have focused on promoter polymorphism (5-HTTLPR) in the serotonin
transporter gene (SLC6A4) or Val66Met polymorphism in brain-derived
neurotrophic factor (BDNF) [7, 8]. Although multiple meta-analyses of gene–
environment (G6E) interactions between 5-HTTLPR and SLEs have not shown
significant associations with MDD [9, 10, 11], little is known about other genes
that may interact with SLEs. Furthermore, even if there is no G6E interaction for
MDD, SLEs should be taken into account for accurately evaluating the SNP risk as
a main effect on the complex phenotype, such as MDD.
The aim of this study was to examine the associations between depressive
symptoms, environmental/clinical factors, and genetic variants. In addition to
SNPs or variants of candidate genes identified from GWASs of MDD, we selected
SNPs on the basis of previous GWASs of SCZ and BD because risk SNPs have
pleiotropic effects on psychiatric disorders [12]. All subjects used in this study
were nurses working in a university hospital who had a higher risk for developing
MDD than the general population, probably because their work involves a high-
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degree of responsibility and requires high motivation and long work periods,
including night shifts.
Materials and Methods
Ethics statements
Written informed consent was obtained from each subject after the procedures
had been fully explained. This study was performed in accordance with the World
Medical Association’s Declaration of Helsinki and approved by the ethics
committees at Fujita Health University.
Subjects
All participants were nurses working at Fujita Health University Hospital, and
were self-identified as members of the Japanese population. We approached 1296
subjects, and a total of 926 (response rate, 71.4%: 90 males and 836 females; mean
age, 29.3 years; range, 20–62 years) agreed to participate. However, four
participants were excluded due to insufficient answer for the following
questionnaire.
The samples were collected in two phases: April 2012 (835 subjects) and April
2013 (87 subjects). All subjects were evaluated for (1) depressive symptoms
according to the Beck Depressive Inventory I (BDI; a 20-item questionnaire) [13];
(2) SLEs according to the List of Threatening Events (LTE) Questionnaire [14]
(12 life events within 6 months that were found to have long-term negative effects
on most people); and (3) personality traits according to the Neuroticism–
Extraversion–Openness Five-Factor Inventory [15] (NEO-FFI; 60 items assessing
five personality traits, including neuroticism, extraversion, openness to experi-
ence, agreeableness, and conscientiousness).
SNP selection, genotyping, and quality control
We listed a total of 63 SNPs/variants in this study (S1 Table). Fifty-nine SNPs
were selected from GWAS data published prior to December 2013, and the
following selection criteria were used: the P value must have been 1) ,161024 in
mega-analysis of GWASs for MDD [3] (18 SNPs); 2) ,161027 in mega-analysis
of GWAS (based on the results of the primary or the combined results) for BD [5]
(five SNPs); 3) ,161027 in mega-analysis of GWASs based on the primary
results (SNPs in linkage equilibrium defined by PGC or SNPs in non-MHC region
were included) or in those based on the combined results for SCZ [4] (32 SNPs);
and 4) ,561028 in mega-analysis of GWASs for five major psychiatric disorders
(four SNPs; however, one SNP, rs1024582, was excluded because of a known LD,
with other CACNA1C SNPs. Thus, three SNPs were included) [12]. Another three
SNPs and one variant (5-HTTLPR) were selected on the basis of candidate gene
(SLC6A4 [9, 10, 11], BDNF [8], FKBP5 [16, 17], and DBH) studies, which were
prioritized as risk genes for MDD in score-based analysis [18], with significant P
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values (P,0.05) detected in the PGC-MDD database [3]. We also confirmed that
all SNPs had minor allele frequencies (MAFs) .1% according to the HapMapJPT
panel (phase II or III: MAFs of six SNPs were zero and thus excluded).
The Oragene DNA Self-Collection Kit (DNAgenotek, Ontario, Canada) was
used to collect and extract DNA from the saliva of 922 subjects (89 males and 833
females). We genotyped these SNPs using the Sequenom iPLEX Gold System
(Sequenom, San Diego, CA) according to the manufacturer’s protocol.
Genotyping call performed by using the Typer 4.0 program (Sequenom, San
Diego, CA). Another possible risk variant, 5-HTTLPR, was genotyped by the
TaqMan assay (Life Technologies, Grand Island, NY) in the manner described by
Hu et al [19]. Ninety-six samples were genotyped according to the classical PCR
method, and the concordance rate between the TaqMan and PCR methods was
100%.
In the primer design step, one SNP (rs171748) was excluded. Moreover, in the
optimization step, because of the unacceptable genotyping clustering by visual
inspection, four SNPs (rs114002140, rs2183696, rs11062146 and rs11532322) were
excluded. For quality control, we removed samples and SNPs with call rates
,90% (N of samples 534, N of SNP 50). In addition, SNPs with Hardy-
Weinberg Equilibrium (,0.001: rs393093) and low MAF (,0.01: rs7746199) were
removed. Lastly, four SNPs (rs4687552, rs113113059, rs11191454 and rs4765913)
had proxy SNPs; these were LD pruned using the criterion of r2,0.25 in our
genotyping data. In total, we analyzed 888 samples and 45 SNPs used in
association analysis.
Statistical analysis
The chi-square test was used to test the Hardy–Weinberg equilibrium for
genotype distribution. To compare the clinical backgrounds, Student’s t test for
continuous values (BDI score, age and employment period [20]), the chi-square
test for sex, and the Mann–Whitney U test for SLEs were used. The correlation
between depressive symptoms measured by BDI and personality traits assessed by
NEO-FFI was calculated using the Pearson’s method.
To examine the association of the genetic variants, SLEs, and their interactions
with the depressive symptoms assessed by BDI, multiple logistic regression
analysis was performed for examining the main effects and two-way interactions.
The dependent variable was the categorical phenotype for the depressive state
(depressive subjects: BDI $10; controls: BDI ,10; 297 subjects were assigned to
cases, and the rest were designated as nondepressive subjects) because a previous
study indicated that this threshold could reflect the depressive state [21]. In this
study, approximately 33% of the participants were regarded as being in a
depressive state, and this proportion was similar to that observed in another study
targeting nurses [20]. Genetic variants (additive model), SLEs (0 or.1), and their
interactions (genetic variants 6 SLE) were entered as independent variables with
covariation of sex and age.
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In terms of personality traits, neuroticism particularly showed a very high
correlation with the BDI score; therefore, we excluded the personality traits as
covariates in this model. The significance level was set to P,0.05 (two-tailed). All
statistical analyses were performed by using R or PLINK ver1.07 software [22].
Results
Clinical backgrounds
The clinical backgrounds of all depressive and nondepressive subjects are shown
in Table 1. No significant differences in the distributions of age, sex and
employment period were observed between the two groups, except in the scores
for neuroticism and number of SLEs.
Initial logistic regression analysis (independent variables: age, sex, SLE, and
neuroticism) revealed that neuroticism showed a highly significant association
with the depressive state (S2 Table). Therefore, we examined the correlation
between BDI score and personality traits and found a significant correlation with
neuroticism (Pearson’s r250.60, P52.2610216). When examining the hypothesis
that effects of SNP or interactions between SNP and SLEs are associated with
depressive state, co-linearity is a major problem; therefore, we did not include
neuroticism in the following regression model.
Main effect of SNP and SNP 6 SLE interaction on the depressive
state
Application of the quality control procedure showed that 45 SNPs and 888
subjects were eligible for examination of the main effect of SNP and SNP 6 SLE
interactions on the depressive state. In the logistic regression analysis, SLEs
(experienced or not experienced) were associated with the depressive state for all
SNPs (P50.004224.0610211). The effect size was relatively large, which
indicated that the presence of SLEs has a high impact on developing the depressive
state. Three SNPs showed significant associations as main effects on the depressive
state (Table 2; full results are shown in S3 Table). The top finding was observed at
rs7296288, which was selected on the basis of the BD GWAS results. Even after
correction for multiple testing (Bonferroni), the P value of this SNP remained
significant (Pcorrected50.0424).
The SNP 6 SLE interaction showed a marginally significant association
(P,0.05) only at two loci (rs4523957 and rs7296288), one of which was identical
to the result for the main effect of SNP (rs7296288; Table 2; the full results are
shown in S2 Table). Notably, other candidate variants, including 5-HTTLPR,
BDNF, and FKBP5 were not associated with the depressive state in our sample.
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Discussion
In this study, we determined whether the genetic variants selected on the basis of
previous GWASs of MDD, BD, and SCZ or classical candidate genes were
associated with the depressive state and assumed that there were genetic variant6
SLE interactions (G6E interactions). All our subjects were nurses who worked at
a university hospital; therefore, these subjects did not reflect the risk for depressive
symptoms of the general population. However, because working as a nurse is a
risk factor for the development of MDD owing to hard work, the need to be
highly motivated, and the high level of responsibility, our subject sample set was
regarded as being at high risk for depression.
In this study, we found that SLEs were risk factors for depressive symptoms and
had moderate to high effect magnitudes (odds ratio ,3). This finding is in line
Table 1. Clinical backgrounds of the subjects with depressive state and non-depressive state.
factors total depressive state (BDI $10) non-depressive state (BDI ,10) P-value
gender (male/female) 89/833 30/279 59/554 0.968
BDI* 8.4¡7.3 16.8¡5.9 4.1¡2.9 ,0.0001
Age 29.8¡8.4 29.2¡7.9 30.0¡8.6 0.149
neuroticism 55.2¡10.7 63.3¡8.3 51.1¡9.3 ,0.0001
Employment period (years) 7.8¡8.1 7.2¡7.7 8.1¡8.3 0.117
SLE** 0.38¡0.74 0.61¡0.92 0.20¡0.40 ,0.0001
Numbers represent means ¡ SDs.
*BDI: Beck Depressive Inventory, **SLE: Stressful life event.
doi:10.1371/journal.pone.0115135.t001
Table 2. Significant association of SNPs as main effects and G6E interactions on depressive state.
Chra SNPb BPc gened A1e A2f F Ag F Uh modeli Puncorrected OR
k
6 rs1360780 35607571 FKBP5 T C 0.286 0.240 ADD 0.0255 1.36
ADDxSLE 0.251 0.75
9 rs1108580 136505114 DBH G A 0.148 0.111 ADD 0.0318 1.48
ADDxSLE 0.472 0.79
12 rs7296288 49479968 DHH C A 0.379 0.320 ADD 0.000943j 1.56
ADDxSLE 0.0197 0.58
17 rs4523957 2208899 SMG6 G T 0.281 0.221 ADD 0.462 1.11
ADDxSLE 0.00337 2.24
aChr: chromosome,
bSNP: single nucleotide polymorphism,
cBP: base position,
dClosest gene ¡100 kb,
eA1: minor allele based on total sample,
fA2: alternative allele,
gF A: minor allele frequency in depressive state,
hF U: minor allele frequency in non-depressive state,
iADD: additive model, SLE: stressful life event,
jBold numbers represents significant P values after Bonferroni correction,
kOR: odds ratio.
doi:10.1371/journal.pone.0115135.t002
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with those of previous studies [23, 24]; therefore, the nurses who experienced SLEs
#6 months as measured by LTE required more care to prevent the development
of depression. A personality trait, neuroticism, was highly correlated with the
depressive symptoms evaluated by BDI. This result possibly indicates that
neuroticism is a state reflecting depressive symptoms rather than a trait;
alternatively, as described previously, neuroticism is a strong risk factor for
depression [25, 26]. We cannot determine which possibility is correct; however,
this was not the main issue to be examined in this study.
Logistic regression analysis to determine the main effects of SNP and G6E
interactions revealed that a possible BD risk SNP, rs7296288, had a significant
main effect on depressive symptoms; however, there was a minimal effect of the
G6E interaction. A significant SNP, rs7296288 (downstream of DHH), was
identified in mega-analysis of BD [5]. Because the P value of this SNP in that
study [5] was not at a genome-wide significance level but was marginally above
this threshold, this gene remains unclear as a risk factor for BD. In addition, the
functional relevance of this gene is not clear for the development of BD and/or
MDD till date, although this gene plays a role in male gonadal differentiation and
perineural development in peripheral nerve systems [27]. However, we consulted
the PGC MDD datasets to examine the association between MDD and the
controls in the largest sample set as an independent replication for mood
disorders. We found a marginal level of significance for this SNP, with the same
direction of the effect (P50.00334; risk allele, C; odds ratio 51.07) [3].
Furthermore, Cross-Disorder Group of the Psychiatric Genomics Consortium
revealed a significant association between SNP and psychiatric disorders
(P51.761024; risk allele, C; odds ratio 51.05) [12]. Therefore, even without
considering the G6E interaction, the LD region with this SNP is a possible risk
factor for mood disorders, including MDD and BD, not only for Caucasians but
also for the Japanese population. SLEs as covariates may provide sufficient
enhancement for extracting the risk as a main effect on MDD.
Classical candidate genes such as SLC6A4, BDNF, FKBP5, and DBH that have
been the subjects of extensive research on depression and may have G6E
interactive effects on depression were not associated with the depressive state.
Although the sample size in our study was much smaller than those in recent
meta-analyses of G6E interactions of SLC6A4 [9, 10, 11], our results supported
the negative trend for an association of the effect of 5-HTTLPR in SLC6A4.
Although the most recent meta-analysis of BDNF [8] showed a significant
association of the effect of the G6E interaction on the depression state, as shown
in an individual report of FKBP5 [28], our data could not support these findings.
Comparing previous studies and our present study, the main differences were the
target subject samples, particularly for FKBP5; the main phenotypes in the
previous studies were child and/or adolescent depression [16] or post-traumatic
stress disorder and related depression [17]. Because we did not evaluate SLEs in
childhood, such as child abuse, we could not assess the effects caused by severe
SLEs.
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A couple of limitations should be noted when interpreting our results. First, the
sample size was modest and insufficient for the detection of a small effect size.
Power analysis calculated by QUANTO version 1.2.4 software (http://biostats.usc.
edu/Quanto.html) suggests that the power of the G6E interaction was
insufficient (S4 Table). A larger sample size will be required for future studies.
Second, our depressive subjects were those with BDI scores .10, a score that is
used as a screening threshold for MDD. This approach implies that the ‘‘cases’’ in
our study were not always MDD. However, notably, independent samples from
PGC showed a significant association between rs7296288 and MDD.
In summary, these results suggest that DHH or genes in LD with rs7296288 play
a role in the etiology of depression. However, SNPs selected from MDD/SCZ
GWAS evidence or classical candidate genes showed no significant associations.
The effect size of G6E interactions between the genetic variants and SLEs for
depression were not large, as expected; thus, further studies with larger sample
sizes are required.
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S1 Figure. SNP selection. BD: Bipolar disorder. MDD: Major depressive disorder.
SCZ: Schizophrenia. CDG: Cross-Disorder Group.
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S2 Figure. Quality control of selected SNPs. MAF: minor allele frequency. LD:
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S1 Table. SNP information. abbreviations: Chr: chromosome, gene: closest gene
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S2 Table. Initial logistic regression analysis (independent variables: age,
gender, SLE, and neuroticism). abbreviations: N: Neuroticism, E: Extraversion,
O: Openness, A: Agreeableness, C: Conscientiousness.
doi:10.1371/journal.pone.0115135.s004 (XLSX)
S3 Table. Association analysis of all models including SNPs as main effect and
GxE interaction on depressive state. abbreviations: Chr: chromosome, BP: base
position, gene: closest gene +/2100 kb, A1: minor allele based on total sample,
A2: alternative allele, NMISS: number of non missing subjects, ADD: additive
model, SLE: stressful life event, OR: odds ratio.
doi:10.1371/journal.pone.0115135.s005 (XLSX)
S4 Table. Power analysis. Assuming: N of subjects: 300 case vs 600 control,
significance: 0.05 (two-tailed), mode of inheritance: Log additive, effect size of
gene (RG): 1.2 and effect size of environment (RE): 2. RGE: risk of GxE interaction.
doi:10.1371/journal.pone.0115135.s006 (XLSX)
SNP in DHH Associated with Depressive State: GxE Interaction Analysis
PLOS ONE | DOI:10.1371/journal.pone.0115135 December 17, 2014 8 / 10
Acknowledgments
We thank Ms M Aizawa, Ms M Miyata, Ms S Umekage, Ms M Uchida and Ms M
Katayama for their technical support.
Author Contributions
Conceived and designed the experiments: MI NI. Performed the experiments: AS
KK TS KE YO KM MI. Analyzed the data: AS KK TS MI. Contributed reagents/
materials/analysis tools: MI KE YO KM NI. Wrote the paper: AS MI NI.
References
1. Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, et al. (2011) Cross-national epidemiology
of DSM-IV major depressive episode. BMC Med 9: 90.
2. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and
meta-analysis. Am J Psychiatry 157: 1552–1562.
3. Ripke S, Wray NR, Lewis CM, Hamilton SP, Weissman MM, et al. (2013) A mega-analysis of genome-
wide association studies for major depressive disorder. Mol Psychiatry 18: 497–511.
4. Ripke S, O’Dushlaine C, Chambert K, Moran JL, Kahler AK, et al. (2013) Genome-wide association
analysis identifies 13 new risk loci for schizophrenia. Nat Genet 45: 1150–1159.
5. Psychiatric GWAS Consortium Bipolar Disorder Working Group (2011) Large-scale genome-wide
association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet 43:
977–983.
6. Regier DA, Narrow WE, Clarke DE, Kraemer HC, Kuramoto SJ, et al. (2013) DSM-5 field trials in the
United States and Canada, Part II: test-retest reliability of selected categorical diagnoses.
Am J Psychiatry 170: 59–70.
7. Caspi A, Hariri AR, Holmes A, Uher R, Moffitt TE (2010) Genetic sensitivity to the environment: the
case of the serotonin transporter gene and its implications for studying complex diseases and traits.
Am J Psychiatry 167: 509–527.
8. Hosang GM, Shiles C, Tansey KE, McGuffin P, Uher R (2014) Interaction between stress and the
BDNF Val66Met polymorphism in depression: a systematic review and meta-analysis. BMC Med 12: 7.
9. Risch N, Herrell R, Lehner T, Liang KY, Eaves L, et al. (2009) Interaction between the serotonin
transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis. JAMA 301:
2462–2471.
10. Munafo MR, Durrant C, Lewis G, Flint J (2009) Gene X environment interactions at the serotonin
transporter locus. Biol Psychiatry 65: 211–219.
11. Karg K, Burmeister M, Shedden K, Sen S (2011) The serotonin transporter promoter variant (5-
HTTLPR), stress, and depression meta-analysis revisited: evidence of genetic moderation. Arch Gen
Psychiatry 68: 444–454.
12. Cross-Disorder Group of the Psychiatric Genomics Consortium (2013) Identification of risk loci with
shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 381: 1371–1379.
13. Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl
Pharmacopsychiatry 7: 151–169.
14. Brugha T, Bebbington P, Tennant C, Hurry J (1985) The List of Threatening Experiences: a subset of
12 life event categories with considerable long-term contextual threat. Psychol Med 15: 189–194.
15. Costa PT, McRae RR (1992) Professional manual: Revised NEO Personality Inventory (NEO-PI-R) and
NEO Five-Factor- Inventory (NEO-FFI) Psychological Assessment Resources. Odessa, FL.
SNP in DHH Associated with Depressive State: GxE Interaction Analysis
PLOS ONE | DOI:10.1371/journal.pone.0115135 December 17, 2014 9 / 10
16. Zimmermann P, Bruckl T, Nocon A, Pfister H, Binder EB, et al. (2011) Interaction of FKBP5 gene
variants and adverse life events in predicting depression onset: results from a 10-year prospective
community study. Am J Psychiatry 168: 1107–1116.
17. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, et al. (2008) Association of FKBP5
polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults.
JAMA 299: 1291–1305.
18. Kao CF, Fang YS, Zhao Z, Kuo PH (2011) Prioritization and evaluation of depression candidate genes
by combining multidimensional data resources. PLoS One 6: e18696.
19. Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, et al. (2006) Serotonin transporter promoter gain-of-
function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78: 815–826.
20. Boya FO, Demiral Y, Ergor A, Akvardar Y, De Witte H (2008) Effects of perceived job insecurity on
perceived anxiety and depression in nurses. Ind Health 46: 613–619.
21. Adachi Y, Aleksic B, Nobata R, Suzuki T, Yoshida K, et al. (2012) Combination use of Beck
Depression Inventory and two-question case-finding instrument as a screening tool for depression in the
workplace. BMJ Open. 2
22. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, et al. (2007) PLINK: a tool set for whole-
genome association and population-based linkage analyses. Am J Hum Genet 81: 559–575.
23. Tao M, Li Y, Xie D, Wang Z, Qiu J, et al. (2011) Examining the relationship between lifetime stressful life
events and the onset of major depression in Chinese women. J Affect Disord 135: 95–99.
24. Peyrot WJ, Middeldorp CM, Jansen R, Smit JH, de Geus EJ, et al. (2013) Strong effects of
environmental factors on prevalence and course of major depressive disorder are not moderated by 5-
HTTLPR polymorphisms in a large Dutch sample. J Affect Disord 146: 91–99.
25. Farmer A, Redman K, Harris T, Mahmood A, Sadler S, et al. (2002) Neuroticism, extraversion, life
events and depression. The Cardiff Depression Study. Br J Psychiatry 181: 118–122.
26. Fried EI, Nesse RM, Zivin K, Guille C, Sen S (2013) Depression is more than the sum score of its parts:
individual DSM symptoms have different risk factors. Psychol Med: 1–10.
27. Umehara F, Tate G, Itoh K, Osame M (2002) Minifascicular neuropathy: a new concept of the human
dinsease caused by desert hedgehog gene mutation. Cell Mol Biol 48: 187–189.
28. Zannas AS, Binder EB (2014) Gene-environment interactions at the FKBP5 locus: sensitive periods,
mechanisms and pleiotropism. Genes Brain Behav 13: 25–37.
SNP in DHH Associated with Depressive State: GxE Interaction Analysis
PLOS ONE | DOI:10.1371/journal.pone.0115135 December 17, 2014 10 / 10
